Fitzsimons Innovation Community Breaks Ground on First Full-Scale Commercial Manufacturing Facility, for Cell and Gene Therapy

Fitzsimons Innovation Community Bioscience 5 Groundbreaking_8.12.21

AURORA, Colo. (August 12, 2021) – Today, Fitzsimons Innovation Community breaks ground on its
new bioscience building, Bioscience 5, further delivering on the Community’s vision to advance
health and care. The 90,000 square-foot facility is the first building in the Fitzsimons Innovation
Community with full-scale manufacturing, for cell and gene therapy. Bioscience 5 is designed to
support its member companies’ overall development and optimize the scientific advancements within
the Community ecosystem.

Bioscience 5 represents the next stage of planned expansion for Fitzsimons Innovation Community,
which currently encompasses four buildings dedicated to advancing life sciences discoveries. The
addition of Bioscience 5 brings the total amount of square footage under management to 429,000.
Fitzsimons Innovation Community is growing with companies from an incubator with small start-ups
(Bioscience 1) to growth- and later-stage companies (Bioscience 2 and Bioscience 3), and the ability
for commercial companies to continue scaling in Bioscience 5 with cell and gene therapy
manufacturing to take significant products to market.

Steve VanNurden, president and chief executive officer of Fitzsimons Innovation Community,
announces the expansion saying, “Fitzsimons Innovation Community invests in a collaborative,
entrepreneurial community to attract innovators representing early-stage, emerging, and established
companies to our region. With our dedicated full-scale cell and gene therapy commercial
manufacturing in the new Bioscience 5, companies will have the ability to grow with us here on our
campus, allowing them to concentrate on health breakthroughs.”

Colorado Life Sciences Ecosystem Remains Strong

Colorado’s life sciences companies raised a combined $704 million during the first quarter of 2021.
VanNurden anticipates continued growth potential for the sector. “Over the past year, the Colorado
life sciences industry has experienced an accelerated pace of investment, a strong talent pipeline,
and breakthrough scientific advancements – signals that the upward trajectory of this sector will
continue.”

The Bioscience 5 state-of-the-art, flexible bioscience facility will accommodate cell and gene therapy
manufacturing, representing a strategic alignment with the University of Colorado Anschutz Medical
Campus, situated directly across the street. The CU Anschutz Medical Campus has national
recognition for its expertise in cell and gene therapy research and innovation, with nine world-leading
researchers in the field, conducting significant clinical trials with the campus health system partners
(UCHealth and Children’s Hospital Colorado), and advancing partnerships with the industry.

Don Elliman, chancellor of the University of Colorado Anschutz Medical Campus and
chairman of the Fitzsimons Innovation Community Board of Directors, describes the value of
the partnership as the ability to foster research and clinical relationships for our Community
members. “Bioscience 5 aligns the Fitzsimons Innovation Community member pipeline of cell and
gene therapy innovation to related expertise on our CU Anschutz Medical Campus.” Fitzsimons
Innovation Community is home to a number of these companies, including Taiga Biotechnologies,
Atara Biotherapeutics, and InVitria.

Fitzsimons Innovation Community Stimulates Local Economy

In early 2020, Fitzsimons Innovation Community opened Bioscience 3, home to growth and
commercial companies that are entering the next phase of developing clinical trial technologies.
Bioscience 3 is currently more than 70-percent leased, and poised for space planning with other
innovative companies. The new groundbreaking of Bioscience 5 demonstrates the quick pace at
which the Community develops.

Aurora Mayor Mike Coffman touts the economic impact of Fitzsimons Innovation Community,
saying, “The City of Aurora values the Fitzsimons Innovation Community collaboration with business
leaders and economic development partners to attract and retain life sciences companies that
stimulate our local economy, provide employment opportunities, and strengthen our community.”
Additional buildings are proposed for Fitzsimons Innovation Community with up to 70 acres available
for life sciences development.

For more information, please visit: www.fitzsimonsinnovation.com

About Fitzsimons Innovation Community
At Fitzsimons Innovation Community, visionaries boldly transform science into the future of health
and care. Our Community pushes boundaries in a unified pursuit of health breakthroughs.
From concept through commercialization, organizations choose Fitzsimons for its entrepreneurial
environment, leading-edge facilities, and campus-wide support. Visionaries discover, develop, and
collaborate with direct access to the renowned clinicians and researchers at the University of
Colorado Anschutz Medical Campus. We are united to advance health.

Media Resources

Images, video, and media resources are available in the Fitzsimons Innovation Community online
news center.

Interviews and tours available upon request.

Media Contact
Annie Coghill
303-547-6692
annie@theprimaveragroup.com